MedPath

Merz Pharmaceuticals, LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

4

FDA:4

Drug Approvals

Xeomin

Approval Date
Sep 14, 2023
FDA

Cuvposa

Approval Date
Sep 13, 2023
FDA

Glycopyrrolate

Approval Date
Jul 15, 2022
FDA

Naftin

Approval Date
Apr 25, 2013
FDA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.